Fineline Cube

Follow:
14778 Articles
Policy / Regulatory

NHSA Updates NRDL Review, Adds Three Domestic Western Medicines

CompanyDrug

Regeneron Secures EU Approval for Ordspono, Its First Bispecific Antibody

Company

BeiGene Positions for Global Growth with Strong Half-Year Results and R&D Investment

Legal / IP

Peking Union Medical College Innovates with Angle Positioning Device Patent Sale

CompanyDeals

China’s WORK Medical Technology Targets U.S. Market with Upcoming IPO

Company

UCB Agrees to USD 680 Million Divestment of China Neurology and Allergy Business to CBC Group and Mubadala

CompanyDeals

Shenzhen Salubris Pharmaceuticals Inks Licensing Deal for YolTech Therapeutics’ YOLT-101 Gene Editing Therapy

CompanyDrug

Shanghai Fudan-Zhangjiang Enrolls First Patient in Phase III Trial for TROP2 ADC FDA018 in TNBC

CompanyDrug

China’s Guilin Sanjin Pharmaceutical Advances BC011 with NMPA Approval for Phase I Clinical Trial

CompanyDeals

Guangzhou Boji Medical and CapitalBio Pharma Form Joint Venture to Innovate in Traditional Chinese Medicine

Company

Shanghai Henlius Biotech Reports 9.8% YOY Revenue Growth and Continued Profitability in 2024H1 Financial Report

CompanyDrug

Changchun High & New Technology Industries Receives FDA Approval for GenSci098 Clinical Trial in Thyroid Eye Disease